Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Comment by jethro549on Nov 20, 2016 12:55pm

126 Views

Post# 25486628

RE:RE:RE:AGM..DEC 22/16.. #7-CONSOLIUDATION AUTHORIZATION

Authorizing a roll back does not mean a roll back is evident. I think with a good property to work like Clone a roll back is not at all necessary. They can attract JV partners, mergers etc.. Roll back is only an option not the only solution. You guys need to relax.

Bullboard Posts

Eminent acquires promising Nevada gold project